Crossmark

“Enhancing Pharmaceutical Accessibility: Evaluating the Impact of Competitive Generic Therapy Exclusivity on Rapid Access of Generics into the U.S. Market (2019–2024)”

Crossref DOI link: https://doi.org/10.1007/s12247-025-09969-4

Published Online: 2025-03-22

Published Print: 2025-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Girhe, Mahesh Kisan

Yerram, Sravani

S, Ajmal C.

V P, Muhammed Nizam

Joga, Ramesh

Khader, Nuwaid

Konda, Pujita

Raghuvanshi, Rajeev Singh

Srivastava, Saurabh
License Information

Text and Data Mining valid from 2025-03-22

Version of Record valid from 2025-03-22
More Information

Article History

Accepted: 7 March 2025

First Online: 22 March 2025

Declarations

:

: The authors declare that they have no conflict of interest.

Document is current

Any future updates will be listed below